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factors and aortic characteristics were assessed using multi-
variable linear regression analyses.
Results Mean age was 31.8 years, 47.6% was male. Aor-
tic wall area was positively associated with age [β = 0.01, 
(95% confidence interval (CI) 2.00 × 10−3, 0.02), 
p = 0.01] and BMI [β = 0.01, (0.01, 0.02), p = 0.003] 
and negatively associated with sex (reference: men) 
[β = −0.06, (−0.11, −0.01), p = 0.02]. Natural logarithm 
transformed (ln) aortic wall thickness was positively asso-
ciated with BMI [β = 0.01, (1.00 × 10−3, 0.02), p = 0.02]. 
Ln aortic PWV was positively associated with 10 mmHg 
increment of SBP [β = 0.06, (0.03, 0.09), p < 0.001] and 
DBP [β = 0.06, (0.02, 0.09), p = 0.006]. No relations were 
observed for smoking and lipids.
Abstract 
Objectives More detailed evaluation of atherosclerosis and 
its key determinants in young individuals is warranted to 
improve knowledge on the pathophysiology of its develop-
ment and progression. This study evaluated associations 
of magnetic resonance imaging (MRI)-derived aortic wall 
area, wall thickness, and pulse wave velocity (PWV) with 
cardiovascular risk factors in asymptomatic, young adults.
Materials and methods In 124 adults (age: 25–35 years) 
from the general population-based Atherosclerosis Moni-
toring and Biomarker Measurements in the Young study, 
demography, anthropometry, and blood samples were col-
lected. The studied MRI-parameters were measured using 
a 3.0T MRI system. Relations between cardiovascular risk 
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Conclusions Already in early adulthood, aortic wall 
geometry and stiffness vary by age, sex, BMI, and blood 
pressure.
Keywords MRI · Risk factors · Health · Young adult
Introduction
The incapacitating sequelae of atherosclerosis remain 
a major contributor to the global burden of disease [1]. 
Hence, prevention of symptomatic atherosclerosis remains 
imperative. Atherosclerosis is a generalized inflammatory 
disease that prompts unfavorable arterial wall remodeling 
from childhood onwards, yet remains clinically dormant 
for years before developing into clinically overt cardiovas-
cular disease (CVD) [2].
Its pattern of disease enables preclinical detection of ath-
erosclerosis. Given that CVD risk rises due to a lengthy and 
cumulative exposure to adverse levels of amenable CV risk 
factors that are already highly prevalent from a young age 
onwards, early detection of atherosclerosis is warranted. 
This may allow for early identification of high-risk indi-
viduals and thus may enable effective treatment of factors 
related to atherosclerosis extent and progression in these 
individuals. In order to achieve this, more detailed under-
standing of the development and progression of atheroscle-
rosis in young individuals is warranted.
In this view, assessment of the presence and extent of 
aortic atherosclerosis using magnetic resonance imaging 
(MRI) may be promising. The aorta is an attractive target 
for the assessment of atherosclerosis in early life since it 
is one of the first arteries to be affected by atherosclerosis 
and the artery where atherosclerosis is most manifest [2, 
3]. MRI has evolved as an attractive modality for in vivo 
evaluation of aortic atherosclerosis in various populations 
since it allows for direct evaluation of the target organ deep 
within the body, is non-invasive and non-ionizing. Further-
more, MRI is able to cover a large anatomical territory, 
has superior soft tissue contrast and can easily be repeated 
sequentially over time [4]. Changes in MRI-derived aortic 
characteristics such as wall thickness, plaque burden, and 
pulse wave velocity (PWV) have consistently been related 
to known CV risk factors and CV events [4–10].
Although MRI is a particularly attractive tool for evalu-
ation of the subtle aortic wall alterations related to athero-
sclerosis, data on this matter in young adults are very lim-
ited [11]. Therefore, the objective of the present study was 
to explore the relation of known CV risk factors with MRI-
derived early signs of atherosclerosis such as aortic wall 
area, wall thickness, and PWV in a population of healthy, 
young adults.
Materials and methods
Study design and study population
The general population-based Atherosclerosis Monitoring 
and Biomarker Measurements in the Young (AMBITYON) 
study (Netherlands National Trial Register number: 4742) 
is a prospective, mono-center cohort study that aimed to 
evaluate the interrelation between classical CV risk fac-
tors, blood biomarkers of arterial inflammation and MRI-
derived atherosclerosis burden in young adulthood. Study 
rationale and detailed description were published recently 
[12]. In short, the AMBITYON study aspires to expand 
current knowledge of the pathophysiology of development 
and progression of atherosclerosis by further clarifying key 
determinants of symptomatic CVD later in life. To date, 
131 participants have been included in the AMBITYON 
study. Individuals were recruited from Leidsche Rijn, a 
district in Utrecht city, the Netherlands. To be suitable for 
enrolment in the AMBITYON study, individuals had to 
be aged between 25 and 35 years and free from (a history 
of) symptomatic CVD, use of CV protective medication, 
cardiac arrhythmias, and contra-indications to MRI (i.e. 
pregnancy). The AMBITYON study was granted approval 
from the institutional review board (IRB) of the University 
Medical Center (UMC) Utrecht (IRB: 13/397). From each 
participant, written informed consent was obtained before 
enrolment.
Demographic information
All AMBITYON study participants filled out a detailed and 
standardized electronic questionnaire that included inquir-
ies on the participant’s demographic profile and health sta-
tus. With this questionnaire, information on CV lifestyle 
risk factors was acquired [13–15].
Anthropometric measurements
Before the MRI examination, body height and weight were 
measured in all participants using a stadiometer and weigh-
ing scale, respectively. The participants were clothed in an 
indoor outfit without shoes and placed in a standing posi-
tion with the feet somewhat apart. Waist and hip circum-
ference were measured halfway between the iliac crest and 
the most distal rib border and at the widest position over 
the major trochanter, respectively. Body mass index (BMI; 
kg/m2) was calculated using height and weight data. Blood 
pressure measurements were obtained using an automated 
oscillometric device with adult cuffs (Welch Allyn, NY, 
USA). Blood pressure was measured twice at the right 
brachial artery after 5 min of rest with the participant in a 
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sitting position and a time interval of 5 min between each 
measurement. Mean systolic (SBP) and diastolic (DBP) 




All participants underwent an MRI examination of the aorta 
in supine posture on a 3.0T multi-transmit clinical MRI 
system (Achieva, Software Release 5.1.7.2, Philips Health-
care, Best, the Netherlands). Imaging was performed using 
a 32-channel phased-array cardiac receiver coil that com-
bines two flexible 16-element coils positioned anterior and 
posterior to the participant. The posterior part of the coil 
is integrated in a housing mattress embedded on the MRI 
table top. The MRI examination was executed within stand-
ard limits of the specific absorption rate (SAR). Before the 
MRI examination, each participant was coached to perform 
end-expiratory breath holding. Total MRI examination time 
was circa 60 min per participant.
Assessment of aortic wall geometry and pulse wave 
velocity
A detailed description of the measurements as mentioned 
below, including the MRI assessment and image analysis 
of aortic wall geometry, thickness, and PWV can be found 
elsewhere [12]. In short, for measurement of aortic wall 
area and thickness, images of the descending thoracic aorta 
were acquired in the sagittal orientation using a 3-dimen-
sional (3D) black-blood (BB), T1-weighted, turbo spin 
echo (TSE) sequence with variable flip angles (3D-T1-BB-
VISTA), a sensitivity encoding (SENSE) parallel imag-
ing algorithm and spectral attenuated inversion recovery 
(SPAIR) fat suppression. Images were acquired during free 
breathing without ECG gating. The black-blood effect was 
realized by intrasequence flow related dephasing. The field 
of view (FOV; 350 × 302 × 45 mm) was placed between 
the top of the aortic arch and the most distal boundary of 
the cardiac coil, spanning approximately 35 cm of descend-
ing thoracic aorta. This FOV enabled full coverage of 
the thoracic descending aorta and a small segment of the 
abdominal aorta.
To assess stiffness of the thoracic aorta, global PWV 
was measured over the whole thoracic aorta as described 
previously [12, 16]. In short, a single-slice, double oblique, 
turbo field gradient-echo survey image was acquired in 
the sagittal orientation with retrospective ECG gating and 
a single end-expiratory breath hold to visualize the full 
course of the thoracic aorta. Based on this image, two 
phase contrast acquisitions with velocity-encoding (VE) 
were planned at right angles to the aortic center lumen line 
to measure the through-plane flow velocity in the ascending 
and proximal descending thoracic aorta (acquisition 1) and 
in the distal descending thoracic aorta (acquisition 2). Flow 
measurements were acquired in the transversal orientation 
using a one-directional, through-plane, non-segmented, VE 
(1.50 m/s), gradient turbo field echo pulse sequence with 
retrospective ECG gating during free breathing. Over one 
cardiac cycle, 50 heart phases were reconstructed (temporal 
resolution of 10–20 ms depending on heart rate, TFE shot 
duration: 38.6 ms; actual temporal resolution: 77.2 ms), 
interpolation: 50%).
MR image analysis
Aortic wall area and thickness were quantified with a vali-
dated software program exclusively equipped for meas-
uring MRI-derived arterial characteristics [Vessel Mass, 
release 5.1, Laboratory for Clinical and Experimental 
Image processing (LKEB), the Netherlands] [11]. Image 
analysis was carried out according to a standardized pro-
tocol [12]. Because of the restricted craniocaudal coverage 
of the reception coil, the aorta was analyzed between the 
beginning of the descending thoracic aorta and the begin-
ning of the celiac trunk. Aortic wall characteristics were 
measured in one image per centimeter of craniocaudal 
coverage. On average 22 cm of descending thoracic aorta 
was analyzed per participant. In the present study, 52 out 
of 2928 images (1.8%, conforming to one image in 52 par-
ticipants) that were used to quantify aortic wall thickness 
and wall area had an insufficient image quality; therefore, 
these images were omitted from analysis. Vessel mass com-
puted the mean aortic wall area and thickness in each par-
ticipant by summing the mean aortic wall area  (cm2) and 
thickness (mm) for all analyzed images in that participant 
and dividing it by the number of analyzed images in that 
participant. An example of the 3D-T1-BB-VISTA acquisi-
tion and a graphic illustration of aortic wall area and thick-
ness quantification is displayed in Fig. 1. In a prior study, 
we demonstrated that inter-scan, as well as inter- and intra-
rater reproducibility of aortic wall measurements using the 
3D-T1-BB-VISTA sequence was excellent [intra-class cor-
relation coefficient (ICC) 0.76-0.99] [12].
Aortic PWV was computed as X/t (m/s). X is the aor-
tic length between the three measurement locations as 
described above; t is the transit time between the arrival 
of the systolic pulse wave front at each of these locations. 
Image analysis was performed conforming to a standard-
ized procedure [17]. In short, to assess PWV, aortic length 
between each measurement location was obtained by 
manually tracing the aorta along its centerline in the dou-
ble oblique image using MASS software [12, 16]. Next, 
with a semi-automatic flow analysis tool in MASS, the 
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outer contours of the ascending and proximal descend-
ing thoracic aorta (acquisition 1), as well as the distal 
descending thoracic aorta (acquisition 2) in all 50 heart 
phases were traced. As such, aortic velocity maps were 
generated. These were further analyzed using a validated 
PWV measurement software program (PwvAppStatic, 
LKEB, Leiden, the Netherlands). The PwvAppStatic uses 
the aortic velocity maps to create velocity–time curves 
and calculates the transit time between the measurement 
locations from these curves. By combining the results of 
the aortic length measurements and transit time absolute 
PWV values for the total thoracic aorta were generated 
using linear regression modelling. An example of the 
double oblique and VE images, as well as an example 
of the PWV measurement method is displayed in Fig. 2. 
PWV was quantified according to a widely used, highly 
reproducible and validated method with excellent inter-
scan, inter-rater, and intra-rater reproducibility (ICC: 
0.87–0.92) [16, 18].
In 7/131 (5.3%) participants, aortic imaging failed due 
to technical malfunction of the cardiac coil. Also, in 6/124 
(4.8%) participants in whom aortic imaging succeeded, 
image quality was considered insufficient for aortic PWV 
quantification. Moreover, in two of 124 (1.6%) remaining 
participants, venous puncture was unsuccessful. Hence, for 
laboratory demographics, aortic wall characteristics and 
aortic PWV, complete case multivariable analysis was per-
formed in 122/131 (93.1%), 124/131 (94.7%), and 118/131 
(90.1%) participants, respectively.
Laboratory assessments
In each participant, a venous blood sample was obtained 
in two tubes: a sodium-heparin tube (3 mL) and EDTA 
tube (2 mL). Immediately after collection, the Laboratory 
of Clinical Chemistry of the UMC Utrecht processed the 
sample and measured total cholesterol, HDL-cholesterol, 
glucose, triglyceride, and C-reactive protein (CRP) levels 
Fig. 1  Illustration of 3D-T1-BB-VISTA sequence and measurement 
of aortic wall geometry (32-year-old female participant). Left illustra-
tion of sagittal and transversal (reconstructed) images of the descend-
ing thoracic aorta acquired using the 3D-T1-BB-VISTA sequence. 
Right illustrations of quantification methods of aortic wall area and 
wall thickness. a, b A schematic and in vivo example of tracing of the 
luminal and outer contours, as well as an aortic wall thickness meas-
urement. c A graphic illustration of the method of quantification of 
aortic wall area and wall thickness. Each zone between two blue lines 
embodies an aortic wall section. In each section, 25 thickness meas-
urements are performed, generating in total 100 thickness measure-
ments per image
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using a routine clinical chemistry analyzer (AU5811, Beck-
man Coulter, Brea, CA, USA). The LDL-cholesterol level 
was computed using the Friedewald formula [19]. Moreo-
ver, white blood cell count (WBC) was measured with a 
hematology analyzer (CellDyn Sapphire, Abbott, Chicago, 
IL, USA). Of note, for CRP levels below detection limit 
(0.5 mg/L) the CRP was estimated by using the mean level 
between zero and the lower detection limit.
Data analysis
Demographic characteristics of the participants were pre-
sented at the participant level as means with standard devi-
ations (SD) or medians with 25th and 75th percentiles (Q1 
and Q3) if they were continuous and had a normal or non-
normal distribution, respectively. Normality of distribution 
of each variable was tested using the Shapiro–Wilk test of 
normality for relatively small sample sizes, histograms, and 
QQ-plots. Categorical characteristics were presented as 
numbers and percentages.
The relations of CV risk factors (independent vari-
ables) with mean aortic wall area  (cm2), wall thickness 
(mm), and mean aortic PWV (m/s) (dependent variables) 
were assessed using linear regression analysis. The studied 
CV risk factors were age, sex (reference category: men), 
smoking (current versus never and former versus never, 
reference category: never), BMI (kg/m2), SBP (mmHg), 
DBP (mmHg), total, HDL and LDL cholesterol level (all in 
mmol/L), and the Framingham Risk Score (FRS) [20]. The 
FRS, a composite score, was calculated for each participant 
by creating risk categories for each FRS risk factor accord-
ing to the FRS cut-off points and consecutively summing 
the points acquired for each risk factor [20]. Two linear 
regression models were constructed. First, a crude model 
(Model 1) was created in which the unadjusted associations 
of the studied CV risk factors with the studied aortic char-
acteristics were evaluated. Subsequently, a multivariable 
model (Model 2) was created, in which we adjusted Model 
1 for the following a priori selected confounders: smok-
ing, BMI, DBP, total, and HDL cholesterol level. Because 
of a high correlation between SBP and DBP (Spearman’s 
r = 0.75) and LDL and total cholesterol (Spearman’s 
r = 0.89) we did not adjust SBP for DBP and LDL for total 
cholesterol. Since the FRS is an accumulated measure of 
CV risk, we did not adjust the FRS for any of the included 
variables.
To meet the mandatory criteria for linear regression 
analyses, mean aortic wall thickness, and PWV were 
transformed using natural logarithm transformation (ln) to 
normalize skewed distributions. Conclusions were based 
Fig. 2  Example of double 
oblique, through-plane velocity-
encoded images and of PWV 
measurement (32-year-old 
female participant). Upper left 
illustration of traced double 
oblique image. Tracing was 
performed along the centerline 
of the aorta to measure aortic 
lengths. Middle/lower left illus-
tration of traced through-plane 
images. Contours were traced 
in the ascending and proximal 
descending aorta (acquisition 
1 middle left) and near the 
dome of the liver (acquisition 
2 lower left) for aortic velocity 
mapping. Right example of 
velocity graph, generated using 
PWVAppStatic. PWV of the 
total thoracic aorta was meas-
ured using linear modelling
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on linear regression coefficients (β) with 95% confidence 
intervals (CI) and p values. A two-sided p value of <0.05 
was considered statistically significant. Data analysis was 




Demographic characteristics of the AMBITYON study 
population are summarized in Table 1. Median age of the 
124 participants under study was 31.8 years (29.1, 34.1); 
59 participants (47.6%) were male. Mean aortic wall area 
was 1.0 cm2 (±0.1) whereas median aortic wall thickness 
and PWV were 1.5 mm (1.4, 1.7) and 4.4 m/s (4.1, 4.8), 
respectively.
Aortic wall geometry
The results of the relation of CV risk factors with aortic 
wall characteristics are listed in Table 2. The multivari-
able linear regression model (Model 2) showed a positive 
relation between mean aortic wall area and age [β = 0.01, 
(95% CI: 2.00 × 10−3, 0.02), p = 0.01] and BMI [β = 0.01, 
(95% CI: 0.01, 0.02), p = 0.003] and a negative relation 
between mean aortic wall area and sex [β = −0.06 (refer-
ence category: men), (95% CI: −0.11, −0.01), p = 0.02]. 
Ln-mean aortic wall thickness was positively related to 
BMI [β = 0.01, (95% CI: 1.00 × 10−3, 0.02), p = 0.02]. 
We did not observe a relation between age and sex and aor-
tic wall thickness, nor did we observe a relation of any of 
the other CV risk factors under study or FRS with aortic 
wall geometry.
Aortic pulse wave velocity
The results of the relation of CV risk factors with ln-mean 
aortic PWV are listed in Table 2. The multivariable linear 
regression model (Model 2) showed a positive relation 
between ln-mean aortic PWV and 10 mmHg increment of 
SBP [β = 0.06, (95% CI: 0.03, 0.09), p < 0.001] and DBP 
[β = 0.06, (95% CI: 0.02, 0.09), p = 0.006]. We did not 
observe a relation of the other CV risk factors under study 
and FRS with aortic PWV.
Of note, additional analyses with aortic characteristics 
dichotomized into ≥75th percentile and <75th percentile 
and additional analyses with CV risk factor levels dichot-
omized into 75th percentile and <75th percentile did not 
change our results.
Discussion
This study investigated the relation between CV risk 
factors and evidence of early atherosclerosis and aortic 
wall stiffness using aortic MRI in young adults without 
known cardiovascular disease. We observed associations 
of CV risk factors with alterations in aortic wall geom-
etry (age, sex, and BMI) and aortic stiffness (SBP and 
DBP) already in young adulthood. To the best of our 
knowledge, this is the first study to report these associa-
tions in an asymptomatic young population using MRI-
derived measures for early subclinical atherosclerosis. 
Using a highly innovative imaging technique, this study 
confirms current knowledge on the relation of CV risk 
factors with subclinical atherosclerosis to young adults in 
whom atherosclerosis related arterial alterations are still 
Table 1  Characteristics of study population
a Q1 25th percentile, Q3 75th percentile, SD standard deviation, BMI 
body mass index, SBP systolic blood pressure, DBP diastolic blood 
pressure, HDL high-density lipoprotein, LDL low-density lipoprotein
N Total population
Demographic characteristics
Age (years), median (Q1, Q3)a 124 31.8 (29.1, 34.1)
 Sex (men), n (%) 124 59 (47.6)
Current cigarette smoking (yes), n (%) 124 27 (21.8)
Former cigarette smoking (yes), n (%) 124 23 (18.5)
Diabetes mellitus (yes), n (%) 124 1 (0.8%)
Anthropometric characteristics
Height (cm), mean (SD)a 124 176.6 (8.8)
Weight (kg), mean (SD)a 124 73.5 (11.6)
Waist circumference (cm), mean (SD)a 124 79.6 (8.8)
Hip circumference (cm), median (Q1, Q3)a 124 87.0 (82.0, 92.0)
BMI (kg/m2), median (Q1, Q3)a 124 23.2 (21.6, 25.0)
SBP (mm Hg), mean (SD)a 124 128.0 (12.0)
DBP (mm Hg), mean (SD)a 124 79.0 (8.0)
Laboratory assessments
Total cholesterol level (mmol/L), mean 
(SD)a
122 4.6 (0.8)
HDL-cholesterol level (mmol/L), median 
(Q1, Q3)a
122 1.4 (1.2, 1.7)
LDL-cholesterol level (mmol/L), mean 
(SD)a
122 2.6 (0.7)
Triglyceride level (mmol/L), median (Q1, 
Q3)a
122 1.2 (0.9, 1.8)
Glucose level (mmol/L), median (Q1, Q3)a 122 5.1 (4.7, 5.5)
MRI derived aortic characteristics
Mean aortic wall area  (cm2), mean (SD)a 124 1.0 (0.1)
Mean aortic wall thickness (mm), median 
(Q1, Q3)a
124 1.5 (1.4, 1.7)
Pulse wave velocity (m/s), median (Q1, 
Q3)a
118 4.4 (4.1, 4.8)
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subtle, and the opportunity for primary prevention is still 
present.
The aortic wall is not a rigid conduit, but a biologically 
dynamic integrated organ that harbors smooth muscle cells, 
endothelial cells, elastin, collagen, and fibroblasts, is able 
to notice hemodynamic stimuli and releases vasoactive ele-
ments [21]. Its structure and function are affected by vari-
ous (un)known pathophysiological factors [3, 21]. Accurate 
evaluation of the arterial wall in young individuals permits 
mapping of its morphology and function and may uncover 
the effects of these factors on its bed. This may further 
unravel the pathophysiology of atherosclerosis and reveal 
factors that influence its development and progression. 
Ultimately, this may provide information to improve pre-
clinical identification of asymptomatic, young individuals 
who are at high-risk for developing clinically overt CVD 
Table 2  Relation between classical cardiovascular risk factors and aortic characteristics
§ p < 0.05
a Values are linear regression coefficients (β) with 95% confidence intervals
b Natural logarithmic transformation was performed
c Model 1: crude model, Model 2: adjusted for age, sex, smoking, BMI, DBP, total cholesterol, and HDL cholesterol
d BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein
e SBP was not adjusted for DBP and LDL cholesterol was not adjusted for total cholesterol
Aortic wall area  (cm2)a
(n = 124)
p value Aortic wall thickness (mm)ab
(n = 124)
p value Aortic PWV (m/s)ab
(n = 118)
p value
Age, per year increasec
Model 1 0.01 (5.00 × 10−3, 2.00) 0.001§ 3.00 × 10−3 (−3.00 × 10−3, 0.01) 0.34 −3.00 × 10−4 (−0.01, 9.00 × 10−3) 0.95
Model 2 0.01 (2.00 × 10−3, 0.02) 0.01§ 2.00 × 10−3 (−4.00 × 10−3, 9.00 × 10−3) 0.48 −1.00 × 10−4 (−0.01, 9.00 × 10−3) 0.99
Sex (reference: men)c
Model 1 −0.07 (−0.11, −0.03) 0.002§ 0.02 (−0.02, 0.06) 0.44 −0.01 (−0.07, 0.05) 0.70
Model 2 −0.06 (−0.11, −0.01) 0.02§ 0.02 (−0.03, 0.07) 0.39 −0.01 (−0.08, 0.05) 0.72
Current smoking (reference: never)c
Model 1 −0.01 (−0.07, 0.04) 0.65 0.01 (−0.04, 0.06) 0.67 0.02 (−0.05, 0.09) 0.60
Model 2 −0.03 (−0.08, 0.03) 0.37 −1.00 × 10−3 (−0.05, 0.05) 0.97 0.01 (−0.06, 0.09) 0.70
Former smoking (reference: never)c
Model 1 0.07 (0.02, 0.13) 0.01 0.01 (−0.04, 0.06) 0.74 0.02 (−0.04, 0.09) 0.48
Model 2 0.04 (−0.02, 0.10) 0.18 0.02 (−0.05, 0.06) 0.93 0.03 (−0.05, 0.09) 0.57
BMI, per kg/m2 increasecd
Model 1 0.01 (0.01, 0.02) 0.001§ 0.01 (1.00 × 10−3, 0.02) 0.03§ 0.01 (−1.00 × 10−3, 0.02) 0.09
Model 2 0.01 (0.01, 0.02) 0.003§ 0.01 (1.00 × 10−3, 0.02) 0.02§ 2.00 × 10−4 (−0.01, 0.01) 0.72
SBP, per 10 mm Hg increasecde
Model 1 0.02 (3.00 × 10−3, 0.04) 0.02§ 0.01 (−0.01, 0.03) 0.19 0.05 (0.03, 0.07) <0.001§
Model 2 3.00 × 10−3 (−0.02, 0.02) 0.74 0.01 (−0.01, 0.03) 0.23 0.06 (0.03, 0.09) <0.001§
DBP, per 10 mm Hg increasecd
Model 1 0.01 (−0.02, 0.04) 0.42 0.01 (−0.02, 0.04) 0.45 0.06 (0.02, 0.09) 0.001§
Model 2 −0.01 (−0.04, 0.02) 0.57 2.00 × 10−3 (−0.03, 0.03) 0.88 0.06 (0.02, 0.09) 0.006§
Total cholesterol, per mmol/L increasec
Model 1 0.01 (−0.02, 0.04) 0.35 4.00 × 10−3 (−0.02, 0.03) 0.74 0.02 (−0.02, 0.05) 0.31
Model 2 −0.01 (−0.04, 0.02) 0.60 −0.01 (−0.04, 0.02) 0.42 0.01 (−0.03, 0.05) 0.77
HDL cholesterol, per mmol/L increasecd
Model 1 −0.04 (−0.10, 0.03) 0.30 0.02 (−0.04, 0.08) 0.59 0.02 (−0.07, 0.11) 0.66
Model 2 0.03 (−0.42, 0.11) 0.39 0.03 (−0.05, 0.10) 0.50 0.04 (−0.06, 0.14) 0.39
LDL cholesterol, per mmol/L increasecde
Model 1 3.00 × 10−3 (−0.03, 0.04) 0.87 1.00 × 10−3 (−0.03, 0.03) 0.93 2.00 × 10−3 (−0.04, 0.04) 0.92
Model 2 −0.02 (−0.05, 0.01) 0.25 −0.01 (−0.04, 0.02) 0.48 −2.00 × 10−3 (−0.05, 0.04) 0.94
Framingham Risk Score, per point increasec
Model 1 3.00 × 10−4 (−4.00 × 10−3, 0.01) 0.89 2.00 × 10−3 (−2.00 × 10−3, 0.01) 0.24 2.00 × 10−3 (−4.00 × 10−3, 0.01) 0.50
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later in life and may enable early initiation of targeted ther-
apy in these individuals.
As an entirely non-invasive imaging modality, MRI-
derived imaging markers for aortic atherosclerosis may 
suit this purpose. Prior studies have assessed the relation of 
CV risk factors with structural and functional MRI-derived 
aortic characteristics in asymptomatic and CV diseased 
populations [5–7, 9]. Most of these studies were less com-
prehensive and mostly incorporated middle to older aged 
individuals. These studies showed that structural and func-
tional aortic characteristics relate to CV risk factors and to 
CV events. Mean thoracic aortic wall area has been related 
to coronary heart disease (CHD) and to CV events [21–23]. 
In addition, descending thoracic aortic mean wall thickness 
increases with age, male sex, current smoking, higher BMI, 
higher SBP, and an unfavorable lipid profile [5–7, 9]. From 
a functional perspective, aortic PWV has shown to be an 
important predictor of CV events and CHD [8, 10, 16, 24, 
25]. PWV predominantly increases with an older age and 
to a lesser extent with a higher SBP, higher DBP, higher 
BMI, abnormal lipid profile, and impaired glucose metabo-
lism [8].
The present results are partially in agreement with prior 
studies. In our study, mean aortic wall area was related 
to age, sex, and BMI. Aortic wall area offers informa-
tion on pathophysiological processes that regulate growth 
and regression of the arterial structure. Aortic wall area 
increases due to aortic wall remodeling, a process that 
involves a variety of structural arterial wall alterations and 
is suggested mostly to occur in the early stages of athero-
sclerosis due to the cumulative impact of various (CV risk) 
factors [23, 26]. Ageing is the major determinant of struc-
tural changes arising in the walls of large arteries. With 
increasing age, arteries dilate and stiffen and show intimal 
thickening [3]. Because of the influence of sex hormones, 
sex is also a major contributor to differences in arterial wall 
dimensions between men and women [27]. Men have larger 
arterial wall dimensions than women. Furthermore, BMI is 
considered an important regulator of early abnormalities in 
arterial wall structure due to its relation to early signs of 
vascular remodeling [9]. Hence, our results appear to be 
biologically plausible.
In addition to aortic wall area, aortic wall thickness 
related to BMI. This has been reported before in healthy 
and CV diseased individuals and seems likely given the 
above-described role of BMI as regulator of early arterial 
wall alterations [2, 9, 10]. However, aortic wall thickness 
did not relate to age and sex in this young population, 
which is interesting as age and sex are usually considered 
the key drivers of atherosclerosis [6, 9, 27, 28]. Moreo-
ver, as opposed to prior studies, aortic wall thickness did 
not relate to any of the other studied CV risk factors. For 
thoracic aortic PWV, we observed a relation with SBP 
and DBP, which is logical given that blood pressure is 
one of the major contributing factors to PWV, yet we did 
not observe a relation between PWV and any of the other 
studied CV risk factors [8].
The lack of detecting associations as observed in prior 
studies is not surprising. Whereas prior studies com-
prised individuals with a large variability in age range, 
ethnic background and atherosclerosis burden, this study 
involved healthy, young individuals, within a narrow age 
range (25–35 years of age) and mostly of Dutch ethnic-
ity (~90%) [5–10, 24]. In addition, our participants had 
a large variation in BMI as compared to the variation in 
blood pressure and lipid levels, which may clarify the 
strong association of BMI with the studied aortic char-
acteristics as compared to the other CV risk factors. Fur-
thermore, it is known that detrimental alterations in arte-
rial wall structure and function are a result of a gradual 
development with age in combination with a cumula-
tive exposure of the arterial wall to (un)known patho-
logic factors (i.e. CV risk factors) over decades, which is 
reflected in the strong association of these aortic charac-
teristics with age [3, 8, 9, 24, 29]. Because of the narrow 
age range, the window of exposure to CV risk factors in 
our study population may not have been large enough to 
exert an effect on aortic characteristics that is visible with 
MRI. Another clarification for the discrepancy in results 
between our and prior studies is the existing heterogene-
ity across studies due to variations in study population, 
sample size, used field strength and sequences, as well as 
in measurement location and quantification method.
Our results warrant validation in larger cohorts. Not 
only may that provide further insight into the pathophysi-
ology and key determinants of atherosclerosis develop-
ment and progression in young adulthood, it may also 
aid in identifying high-risk groups in young adults and 
CV risk factors of target for preventive strategies in 
these individuals. Pre-clinical identification of high-risk 
groups in young adulthood may be realized by develop-
ing a scoring algorithm composed of aggregated CV risk 
factors. This algorithm may improve our ability to risk-
stratify young adults and might permit early initiation of 
tailored therapeutic strategies aimed at modifiable CV 
risk factors. Despite the query whether the window of 
exposure to CV risk factors in young adults has been long 
enough to enable stratification using the above mentioned 
method and despite that existing algorithms assessing CV 
risk do not completely clarify CV risk, to date, no other 
biomarker has demonstrated to be of added value to cur-
rent CV risk scoring algorithms [28, 30].
Strengths of our study are the meticulous random selec-
tion of young, asymptomatic general population-based 
sample and the combined evaluation of aortic morphology 
and function that may be relevant for detection of early 
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manifestations of atherosclerosis. However, it is essential 
to acknowledge limitations. We did not use ECG trigger-
ing or breath holding for the 3D-T1-BB-VISTA sequence, 
neither did we use breath holding for the VE PWV acqui-
sition sequences. Although this is a strength since partici-
pants did not need to follow any commands, pulsation and 
breathing artefacts may have introduced minor measure-
ment errors. However, we do not think this has influenced 
our results since our quantification methods have previ-
ously shown to be highly reproducible and appear to be 
in accordance with the theory of arterial ageing as shown 
in previously published studies [16, 17]. Furthermore, as 
mentioned afore, the direction of the relations observed in 
the present study coincide with biological evidence and 
with directions of similar associations reported in prior 
studies. However, optimization of the 3D-T1-BB-VISTA 
sequence by using acceleration techniques, such as com-
pressed sensing and motion navigators or special motion 
compensation methods may lead to shorter acquisition 
times and improved accuracy of measurement. Moreo-
ver, variation in study methodology due to the lack of a 
clear reference standard for measurement of MRI-derived 
aortic parameters limits the comparison of results across 
studies. Hence, the development of a standardized method 
of measurement and quantification of aortic MRI-param-
eters is required. Second, our study population mainly 
entailed Caucasian adults. Since atherosclerosis may exert 
different effects in other populations, this restricts the 
generalizability of our results. Third, quantification of the 
studied characteristics was time-consuming since it was 
performed semi-automatically. Hence, we only analysed 
a subsample of all available aortic wall data. Therefore, 
we cannot rule out that subtle focal lesions may have 
remained unnoticed. Moreover, the currently used semi-
automated tool requires devoted training of observers who 
perform the image analysis. Hence, to improve efficiency 
of quantification and permit arterial wall evaluation over a 
larger anatomical coverage, the employment of fully auto-
mated quantification tools is merited.
Conclusion
Variations in MRI-derived aortic wall area, wall thickness 
and stiffness can already be detected in young adulthood 
and appear to be determined by age, sex, BMI, and blood 
pressure.
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